医学
同型半胱氨酸
内科学
相对风险
肾脏疾病
叶酸
临床试验
随机对照试验
胃肠病学
外科
置信区间
作者
Xianhui Qin,Yong Huo,Craig B. Langman,Fan Fan Hou,Yundai Chen,Debora Matossian,Xiping Xu,Xiaobin Wang
摘要
Folic acid therapy can reduce CVD risk in patients with ESRD/ACKD by 15%. A greater beneficial effect was observed among those trials with no or partial folic acid fortification or a decrease in Hcy level >20% regardless of folic acid fortification.
科研通智能强力驱动
Strongly Powered by AbleSci AI